Siemens experts have innovated to support COVID-19 crisis response teams, manufacturers, and suppliers to keep operations and supply chains up and running. Our software and automation hardware has been applied to help significantly increase manufacturing throughput for critical products, like PPE. These tools can be used in any existing or new manufacturing facility to increase production capacity or switch existing production lines to produce biopharmaceuticals, PPE, or medical devices.
As the national vaccine rollout begins, antibody testing will support the assessment of vaccine effectiveness, which will play a key role in promoting public health. Siemens Healthineers antibody tests are available across the US on the largest installed base of testing equipment, with high throughput, fast turn-around, and substantial capacity for manufacturing approximately 50 million test kits per month in our Massachusetts and Delaware facilities. Antibody testing can also be used to prove the effectiveness of vaccines, enabling public trust in our nation’s efforts to defeat the virus. Tracking antibody levels in months 3, 6 and 9 following vaccination and annually will help to understand how effective the different vaccines are and how long the antibodies last. To further this effort, Siemens Healthineers has collaborated with The Centers for Disease Control and Prevention (CDC) to standardize and determine antibody levels that are necessary for immunity.
The Siemens Foundation, Siemens Healthineers and Siemens employees have donated more than $9.5 million to address the COVID-19 pandemic in the United States, including $2.13 million to 20 community health centers, $500,000 to the National Governors Association’s Reskilling and Recovery Network, and nearly $3 million in funding and COVID-19 testing technologies to Testing for America to support the safe reopening of historically black colleges and universities (HBCUs) across the country. The latter effort enabled Delaware State University to perform 35,000 tests, testing students twice weekly, to provide in-person instruction during the pandemic.
Most recently the Siemens Foundation donated $1.4 million to support COVID-19 vaccination distribution efforts in Black, Latinx, and Indigenous communities.